E-Ova L 2.5 Tablet
Marketer
Koye Pharmaceuticals Pvt ltd
Salt Composition
Letrozole (2.5mg)
Overview E-Ova L 2.5 Tablet
Post-menopausal women with breast cancer may find relief with E-Ova L 2.5 Tablet. This medication can be administered independently or in conjunction with other therapies, including surgical intervention or radiotherapy. In advanced breast cancer cases, it aids in preventing metastasis. E-Ova L 2.5 Tablet may be ingested with or without food; dosage and duration are determined by the physician to optimize treatment. The prescribed regimen varies depending on the individual's condition and treatment goals. Common side effects, such as increased perspiration, weariness, hot flashes, and elevated cholesterol, should be reported to the physician if they become problematic. Preventive or mitigating strategies may be discussed with your doctor. Prior to commencing treatment, inform your physician of any pre-existing liver or kidney conditions, osteoporosis, or ongoing medications, as these factors can influence efficacy or interact with the medication. Pregnancy or breastfeeding should also be disclosed. Pre- and ongoing treatment may include blood tests assessing vitamin D levels and bone density.
Uses of E-Ova L 2.5 Tablet
Managing breast cancer
Major Benefits of E-Ova L 2.5 Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. E-Ova L 2.5 Tablet can be consumed with or without food, although consistent timing is recommended.
Common Side effects of E-Ova L 2.5 Tablet:
- Dizziness
- Fatigue
- Weakness
- Bone pain
- Back pain
- Night sweats
- Joint pain
- Nausea
- Osteoporosis
- Joint inflammation
- Weight gain
- Hot flushes
- Edema (swelling)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Diaphoresis
- Bone fracture
- Hypercholesterolemia (high cholesterol)
- Cough
- Shortness of breath
How to use E-Ova L 2.5 Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. E-Ova L 2.5 Tablet can be consumed with or without food, although consistent timing is recommended.
How E-Ova L 2.5 Tablet works:
Estrogen production is reduced by the aromatase inhibitor, E-Ova L 2.5 Tablet. This lowers estrogen levels, potentially hindering or halting the growth of estrogen-dependent breast cancers.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant ingestion of alcohol and E-Ova L 2.5 Tablet.
PregnancyUNSAFE
The use of E-Ova L 2.5 Tablet is strongly contraindicated during pregnancy. Pregnant women should consult their physician, as research in both animal and human studies has revealed substantial risks to fetal development.
Breast feedingUNSAFE
Lactation is contraindicated with E-Ova L 2.5 Tablet due to the potential for infant toxicity.
DrivingUNSAFE
Taking E-Ova L 2.5 Tablet may cause drowsiness, blurred vision, and dizziness, reducing alertness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
E-Ova L 2.5 Tablet poses no known safety concerns for individuals with kidney impairment, and dosage modification isn't necessary. Nevertheless, data regarding its use in patients with terminal kidney failure is scarce. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use E-Ova L 2.5 Tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take E-Ova L 2.5 Tablet :
Should you forget to take your E-Ova L 2.5 Tablet, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Never take a double dose.
Facts to Know About E-Ova L 2.5 Tablet
| Label | Value |
|---|---|
| Chemical Classification | Diphenylmethane derivative |
| Developing Habits | No. |
| Treatment Category | Cancer Drugs |






